Syros Pharmaceuticals
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia (NCT04996030) | Syros Pharmaceuticals | 2021-09-17 |
| Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT04905407) | Syros Pharmaceuticals | 2021-08-26 |
| Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome (NCT04797780) | Syros Pharmaceuticals | 2021-02-08 |
| A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors (NCT04247126) | Syros Pharmaceuticals | 2020-01-23 |
Track Syros Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.